Ostomy - ConvaTec SUR-FIT Natura Two-Piece

None of the 43 traditional antibiotics in the clinical pipeline that target WHO priority pathogens, Clostridioides difficile or tuberculosis sufficiently addresses drug resistance, according to a new report. WHOs annual Antibacterial Pipeline Report reviews antibiotic candidates in early development or the clinical stages of testing to assess progress, identify gaps in drug resistance and encourage action to fill those gaps. This years report revealed a near static pipeline, WHO said. It outli...

>Read More

The FDA acceptance of an investigational new drug application and an article diving into Demodex led recent cornea/external disease news on Healio/OSN. Read top-performing cornea coverage below: FDA accepts IND for presbyopia drop The FDA has accepted an investigational new drug application for Brimochol, according to a press release from Visus Therapeutics. Read more. Demodex: Easy to find, not so easy to kill The Demodex mite, of which there are at least 65 species, is the most common micros...

>Read More

Irritable bowel syndrome is one of the most burdensome and chronic ailments with an estimated 45 million people affected in the United States, the International Foundation for Gastrointestinal Disorders reports. Although it is so common, many people remain undiagnosed and unaware their symptoms indicate a recognized disorder. Further, patients are often stigmatized and misunderstood, creating a significant impact on their quality of life. Throughout April, IBS awareness month highlights the im...

>Read More

Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a platform for percutaneous femoral-popliteal bypass for severe peripheral artery disease. PQ Bypass platform (Detour) for percutaneous femoral-popliteal bypass received a Breakthrough Device Designation from the FDA. As Healio previously reported, percutaneous femoral-popliteal bypass was associated with high rates of patency and low rates of complications at 24 months in patients with s...

>Read More

Neeraj Agarwal, MD, has been appointed senior director of clinical research innovation at Huntsman Cancer Institute at University of Utah. Agarwal -- physician-scientist at the cancer institute and professor of internal medicine at the university -- will serve on the senior leadership of the comprehensive cancer center at Huntsman Cancer Institute. He also will oversee key components of the institutes clinical research infrastructure, lead efforts to accelerate the pace at which innovative cli...

>Read More

NuVasive Inc. has announced FDA approval of the Simplify cervical artificial disc for two-level cervical total disc replacement, according to the release. An addition to NuVasives C360 portfolio of spinal surgery technology, the Simplify disc achieved an overall success rate nearly 10% higher compared with anterior cervical discectomy and fusion, according to the release. This approval is an incredible achievement for the Simplify disc and further broadens the growth opportunities for the NuVa...

>Read More

The U.S. public health community was unable to foresee the rampant politicization of the COVID-19 pandemic, and was shocked by the initial federal response, according to New York Times bestselling author John M. Barry. Barry, whose book, The Great Influenza: The Epic Story of the Greatest Plague in History, won the 2005 Keck Communication Award from the United States National Academies of Sciences, Engineering, and Medicine, was asked during a virtual Q&A session at the 2021 Interdisciplinary ...

>Read More

Product Listings for Ostomy - ConvaTec SUR-FIT Natura Two-Piece